We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+2.35%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$24.3B
AUM Growth
-$663M
(-2.7%)
Cap. Flow
-$1.37B
Cap. Flow
% of AUM
-5.66%
Top 10 Holdings %
Top 10 Hldgs %
15.29%
Holding
1,567
New
158
Increased
553
Reduced
532
Closed
145
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$130M |
| 2 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$126M |
| 3 |
MetLife
MET
|
+$107M |
| 4 |
General Mills
GIS
|
+$92.4M |
| 5 |
Parker-Hannifin
PH
|
+$71.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$199M |
| 2 |
RTN
Raytheon Company
RTN
|
+$151M |
| 3 |
Delta Air Lines
DAL
|
+$148M |
| 4 |
Norfolk Southern
NSC
|
+$145M |
| 5 |
Boston Scientific
BSX
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.77% |
| 2 | Financials | 14.55% |
| 3 | Technology | 14.11% |
| 4 | Consumer Discretionary | 8.63% |
| 5 | Industrials | 8.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
The Mosaic Company
MOS
$8.09B
| $3.61M | 0.01% |
+78,450
| New | +$3.83M |
|
|
DF
652
DELISTED
Dean Foods Company
DF
| $3.61M | 0.01% |
218,300
+98,500
| +82% | +$1.69M |
|
|
NFX
653
DELISTED
Newfield Exploration
NFX
| $3.6M | 0.01% |
102,455
-277,428
| -73% | -$8.41M |
|
654
Macerich
MAC
$6.35B
| $3.57M | 0.01% |
42,291
+25,342
| +150% | +$2.22M |
|
655
McCormick & Company Non-Voting
MKC
$13.4B
| $3.57M | 0.01% |
92,498
-9,140
| -9% | -$339K |
|
|
WPS
656
DELISTED
iShares International Developed Property ETF
WPS
| $3.55M | 0.01% |
93,040
+2,230
| +2% | +$84.5K |
|
657
Carnival Corporation Ltd
CCL
$30.3B
| $3.52M | 0.01% |
73,500
+11,400
| +18% | +$513K |
|
658
Brown-Forman Class B
BF.B
$12B
| $3.5M | 0.01% |
120,938
-653,312
| -84% | -$18.8M |
|
|
CSGS
659
DELISTED
CSG Systems International
CSGS
| $3.5M | 0.01% |
115,000
-109,800
| -49% | -$3.08M |
|
660
Greif
GEF
$4.63B
| $3.5M | 0.01% |
+89,000
| New | +$3.64M |
|
|
EQM
661
DELISTED
EQM Midstream Partners, LP
EQM
| $3.5M | 0.01% |
45,000
-13,000
| -22% | -$1.07M |
|
662
Newmont
NEM
$131B
| $3.48M | 0.01% |
160,193
+10,427
| +7% | +$244K |
|
663
TechnipFMC
FTI
$29.4B
| $3.48M | 0.01% |
126,202
+21,908
| +21% | +$642K |
|
664
Dollar Tree
DLTR
$21.2B
| $3.45M | 0.01% |
42,476
-15,400
| -27% | -$1.17M |
|
|
DCH
665
Dauch Corp
DCH
$1.45B
| $3.44M | 0.01% |
+133,100
| New | +$3.27M |
|
666
REX American Resources
REX
$1.41B
| $3.43M | 0.01% |
338,400
+600
| +0.2% | +$5.76K |
|
|
RRMS
667
DELISTED
ROSE ROCK MIDSTREAM L P COM UNIT REPSTG LTD (DE)
RRMS
| $3.37M | 0.01% |
71,000
+1,000
| +1% | +$43.8K |
|
668
Synaptics
SYNA
$3.81B
| $3.33M | 0.01% |
41,000
+3,400
| +9% | +$257K |
|
669
Silicon Laboratories
SLAB
$7.34B
| $3.33M | 0.01% |
65,588
-1,412
| -2% | -$68.5K |
|
670
Bunge Global
BG
$23.4B
| $3.33M | 0.01% |
+40,400
| New | +$3.45M |
|
|
ECOM
671
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $3.32M | 0.01% |
342,413
+11,176
| +3% | +$124K |
|
|
ACOR
672
DELISTED
Acorda Therapeutics
ACOR
| $3.29M | 0.01% |
825
-111
| -12% | -$508K |
|
673
Insulet
PODD
$9.66B
| $3.27M | 0.01% |
98,139
-77,911
| -44% | -$2.63M |
|
674
Brink's
BCO
$4.48B
| $3.25M | 0.01% |
117,500
-6,700
| -5% | -$172K |
|
675
Equifax
EFX
$19.6B
| $3.25M | 0.01% |
34,900
-163,900
| -82% | -$14.5M |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q1 2015 Portfolio in Review
As of Q1 2015, Axa held 1,567 positions worth $24.3B, down 2.7% from $24.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Axa withdrew a net $1.37B in Q1 2015, closing 145 positions and reducing 532 holdings. Its most notable exit was Viatris, an estimated $55.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Financials and Technology.
Against the trend, Axa opened a new position in Nasdaq worth $42.1M.
- Axa's largest Q1 2015 buy was Nasdaq: 2,480,223 shares worth $42.1M.
- Axa added most to Johnson & Johnson in Q1 2015, an estimated $130M increase.
- Axa's biggest Q1 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $199M.
- Axa fully exited Viatris in Q1 2015, selling an estimated $55.8M.
- Axa's ten largest holdings make up 15% of its $24.3B portfolio in Q1 2015.
- Axa opened 158 new positions and closed 145 in Q1 2015.
- Axa's portfolio value fell 2.7% quarter-over-quarter to $24.3B.
Based on Axa's 13F filing for Q1 2015, filed 13 May 2015.